CK5/6, EGFR, Ki-67, cyclin D1, and nm23-H1 protein expressions as predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer patients.

Abstract

The purpose of this study was to evaluate the importance of biological markers to predict pathologic complete response (pCR) to neoadjuvant chemotherapy (NCT) in patients with locally advanced triple-negative breast cancers (TNBCs). Forty-one patients (18.6%) among 220 breast cancer patients were identified as TNBCs from March 2006 to 2009 were included in… (More)
DOI: 10.1007/s12032-010-9742-6

Topics

Cite this paper

@article{Li2011CK56EK, title={CK5/6, EGFR, Ki-67, cyclin D1, and nm23-H1 protein expressions as predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer patients.}, author={Xi-ru Li and Mei Liu and Yan-jun Zhang and Jiandong Wang and Yi-qiong Zheng and Jie Li and Bing Ma and Xin Song}, journal={Medical oncology}, year={2011}, volume={28 Suppl 1}, pages={S129-34} }